Drug price discounting is becoming more frequent and complex as industry and health care systems struggle to balance access and affordability. Leela Barham considers the pros and cons of keeping ...

The America First Policy Institute — the think tank founded and staffed by Trump officials to advance his vision for the ...

President Donald Trump’s allies are resurfacing a proposal from the first Trump administration that would dramatically cut ...

NEW YORK (Reuters) - Drugmakers including Pfizer Inc <PFE.N>, GlaxoSmithKline PLC <GSK.L> and Sanofi SA <SASY.PA> are planning to hike U.S. list prices on more than 200 drugs in the United States ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

The Inflation Reduction Act of 2022 marked a significant shift in US ... list of drugs is exempted from the program. This is not the case in other countries that have long practiced drug price ...

Since being first introduced to the market, manufacturers have steadily increased the list prices on the first 10 drugs selected for ... brands Receive email from us on behalf of our trusted ...

Congressmen August Pfluger (TX-11) and Don Davis (NC-01) introduced bipartisan legislation last week to lower out-of-pocket ...

NEW YORK (Reuters): Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer Covid-19 treatment Paxlovid, Bristol Myers Squibb's cancer cell therapies and vaccines ...

Australia trade war has left consumers wondering what this means for them. At least in the short term, it looks like good ...

John Cornyn, R-Texas, introduced legislation on Wednesday that aims to reduce prescription drug costs ... on the lower net price of the medication, rather than its higher list price, according ...